3rd Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$510,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

DEA scheduling of controlled substances H.R. 639/S 481 - Improving Regulatory Transparency for New Medical Therapies Act

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 639 (114th)

Health Issues HCR

Legislative discussions related to issues of health care pricing, value and outcomes. Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54) Regulatory and legislative health care issues, including the 340B program HR6 - 21st Century Cures Act

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Trade (domestic/foreign) TRD

IP issues related to the Trade Promotion Authority and Trans Pacific Partnership HR 9/S 1137 - The Innovation Act/PATENT Act HR 1314/S 995 - Trade Act of 2015/Bipartisan Congressional Trade Priorities and Accountability Act of 2015

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th), H.R. 1314 (114th)

Defense DEF

DoD/TRICARE coverage of FDA-approved obesity drugs National Defense Authorization Bill for 2016 (HR 1735/S 1376) Department of Defense Appropriations Bill for 2016 (HR 2685/S 1558)

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1735 (114th), H.R. 2685 (114th)

Medicare/Medicaid MMM

Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 H.R. 2404/S 1509 - Treat and Reduce Obesity Act of 2015

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 810 (114th), H.R. 2 (114th), H.R. 2404 (114th)

Budget/Appropriations BUD

Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products H Con Res 27 - Establishing the budget for the United States Government for FY 2016 and setting forth appropriate budgetary levels for FYs 2017 through 2025. S Con Res 11 - An original concurrent resolution setting forth the congressional budget for the United States Government for Fiscal Year 2016 and setting for the appropriate budgetary levels for fiscal years 2017 through 2025.

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 11 (114th), H.Con.Res. 27 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.